An access approach that’s built to last as long as the treatment does.
Benefits
28 years, 100+ countries—no one else compares
Purpose-built to overcome the challenges of emerging markets and LMICs
90% Of top 20 pharmaceutical companies have partnered with Axios
Offices and teams on the ground around the world
Strong relationships with governments, hospitals, clinics, and NGOs worldwide
Access solutions built around patients and designed to last, not just launch
Our view
Solutions
Access is multi-dimensional. Our solutions address the barriers patients face throughout their treatment journey, helping more patients access and stay on the treatment they need to maximize medical outcomes.
How We Work
No one-size-fits-all: we tailor our access approach with rich data, align stakeholders around common ground, and refine continuously, backed by strong compliance and smart digital tools.
By The Number
28
Years
10m+
Patients
100+
Countries
240+
Current access programs
“The constant monitoring and support [provided by Axios] throughout my treatment period helped to control and mitigate the progression of the disease while providing me with a better quality of life.”
Peru, Living with Lung Cancer
“My doctor then told me about this program that could help me, and together we filled in the application form. I got a call from the program team less than 24 hours later, introducing the program and requesting a few documents….I am still amazed at how fast and simple the process was.”
Kenya, Living with Chronic Myeloid Leukemia
“After undergoing the financial assessment by Axios for the Axios-partnered patient assistance program, I was relieved and happy. It reduced my worries and alleviated my financial issues related to getting the treatment.”
Malaysia, Living with Breast Cancer
Axios in Action
Axios combined personalized financial support with zero-interest cash-gap funding to help Malaysian patients start and stay on treatment without delays caused by affordability or reimbursement gaps.
Resources
Best practices to help close critical access to healthcare gaps around the world.
